These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The role of diet on gut microbiota composition. Bibbò S; Ianiro G; Giorgio V; Scaldaferri F; Masucci L; Gasbarrini A; Cammarota G Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4742-4749. PubMed ID: 27906427 [TBL] [Abstract][Full Text] [Related]
49. The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease. Wu GD Nestle Nutr Inst Workshop Ser; 2016; 84():103-10. PubMed ID: 26764479 [TBL] [Abstract][Full Text] [Related]
50. The Microbiome-Gut-Brain Axis in Health and Disease. Dinan TG; Cryan JF Gastroenterol Clin North Am; 2017 Mar; 46(1):77-89. PubMed ID: 28164854 [TBL] [Abstract][Full Text] [Related]
51. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice. Wu Q; Yang X; Zhang Y; Zhang L; Feng L Exp Neurol; 2016 Nov; 285(Pt A):61-71. PubMed ID: 27637804 [TBL] [Abstract][Full Text] [Related]
52. Nutritional influences in selected gastrointestinal diseases. Lakatos PL; Kiss LS; Miheller P Dig Dis; 2011; 29(2):154-65. PubMed ID: 21734379 [TBL] [Abstract][Full Text] [Related]
53. Gut microbiota in the pathogenesis of inflammatory bowel disease. Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689 [TBL] [Abstract][Full Text] [Related]
54. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Collins LM; Toulouse A; Connor TJ; Nolan YM Neuropharmacology; 2012 Jun; 62(7):2154-68. PubMed ID: 22361232 [TBL] [Abstract][Full Text] [Related]
55. Foodomics as part of the host-microbiota-exposome interplay. Putignani L; Dallapiccola B J Proteomics; 2016 Sep; 147():3-20. PubMed ID: 27130534 [TBL] [Abstract][Full Text] [Related]
56. The colon revisited or the key to wellness, health and disease. Gonzalez-Correa CA; Mulett-Vásquez E; Miranda DA; Gonzalez-Correa CH; Gómez-Buitrago PA Med Hypotheses; 2017 Oct; 108():133-143. PubMed ID: 29055387 [TBL] [Abstract][Full Text] [Related]
57. Neural control of the gastrointestinal tract: implications for Parkinson disease. Cersosimo MG; Benarroch EE Mov Disord; 2008 Jun; 23(8):1065-75. PubMed ID: 18442139 [TBL] [Abstract][Full Text] [Related]
58. Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome. de Toro-Martín J; Arsenault BJ; Després JP; Vohl MC Nutrients; 2017 Aug; 9(8):. PubMed ID: 28829397 [TBL] [Abstract][Full Text] [Related]
59. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease. Scheider WL; Hershey LA; Vena JE; Holmlund T; Marshall JR; Freudenheim Mov Disord; 1997 Mar; 12(2):190-6. PubMed ID: 9087977 [TBL] [Abstract][Full Text] [Related]
60. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Ghaisas S; Maher J; Kanthasamy A Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]